Login

Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A. 00:10:00

Share On Facebook Share On Twitter

João Bento is the CEO of CTT Correios de Portugal, S.A.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
GreenRoc Mining Welcomes Significant Changes in Greenlandic Mining Laws | Dr. Stefan Bernstein, CEO, GreenRoc Mining PLC.
00:00:00
Day 4 of the 2024 Mining Indaba: Keamogetswe Mpofu's Mechanical Engineering PIT | DR. NOMBASA TSENGWA ,CHIEF EXECUTIVE OFFICER (MEMBER SOCIAL, ETHICS AND RESPONSIBILITY COMMITTEE), EXXARO RESOURCES LTD
00:10:00
Mobile Parts: Your Solution for Equipment Needs | Darren Bissonnette , Manager of Information Technology of Mobile Parts inc.
00:10:00
From Cargill to Leading Global Alternatives - A Journey of Value Investing, Leadership, and Empowering Diversity in Finance
00:10:00
Delivering Predictable Distributions and Sustainable Growth: The Arena REIT Approach to Social Infrastructure Investment|CEO , Arena Reit No 1
00:10:00
Maulik Patel, Executive Director of Sahajanand Laser Technology Ltd, discusses IMTEX FORMING 2024.
00:10:00
UTI AMC's CEO Imtaiyazur Rahman on Growth Strategies and Market Positioning | Imtaiyazur Rahman, CEO, UTI Asset Management Co. ltd.
00:10:00
Ardea Resources: Kalgoorlie Nickel Project Update
00:10:00
Building Startups In The Right Now Economy|Mark Siegel,Managing Director,Menlo Ventures
00:10:00
Building Strong Foundations: Nurturing Excellence in Education and Finance | Sir John Kingman , Chairman , Legal & General.
00:10:00
CEO Review: Blue Bird Vision Diesel Bus on PIT Grand Tour | Phil Horlock - CEO of Blue Bird Corporation
00:10:00
Emanuele Galtieri on Cybersecurity and Public-Private Partnerships at CyberSec2023 | Emanuele Galtieri, CEO, CY4Gate SpA.

© 2017 - Neuhu+